JP2022535694A5 - - Google Patents
Info
- Publication number
- JP2022535694A5 JP2022535694A5 JP2021569057A JP2021569057A JP2022535694A5 JP 2022535694 A5 JP2022535694 A5 JP 2022535694A5 JP 2021569057 A JP2021569057 A JP 2021569057A JP 2021569057 A JP2021569057 A JP 2021569057A JP 2022535694 A5 JP2022535694 A5 JP 2022535694A5
- Authority
- JP
- Japan
- Prior art keywords
- extended
- release composition
- manufactured article
- use according
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962853153P | 2019-05-27 | 2019-05-27 | |
| US62/853,153 | 2019-05-27 | ||
| PCT/IB2020/054984 WO2020240417A1 (en) | 2019-05-27 | 2020-05-26 | Leuprolide acetate compositions and methods of using the same to treat breast cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022535694A JP2022535694A (ja) | 2022-08-10 |
| JP2022535694A5 true JP2022535694A5 (enExample) | 2023-06-05 |
| JP7664855B2 JP7664855B2 (ja) | 2025-04-18 |
Family
ID=70922081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569057A Active JP7664855B2 (ja) | 2019-05-27 | 2020-05-26 | 乳がんを処置するためのリュープロリド酢酸塩組成物およびその使用方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US12453754B2 (enExample) |
| EP (1) | EP3975990A1 (enExample) |
| JP (1) | JP7664855B2 (enExample) |
| KR (1) | KR20220041782A (enExample) |
| CN (1) | CN114144169A (enExample) |
| AR (1) | AR119021A1 (enExample) |
| AU (1) | AU2020284587B2 (enExample) |
| BR (1) | BR112021023904A2 (enExample) |
| CA (1) | CA3141456A1 (enExample) |
| EA (1) | EA202193257A1 (enExample) |
| IL (1) | IL288503A (enExample) |
| MX (1) | MX2021014540A (enExample) |
| PH (1) | PH12021552976A1 (enExample) |
| SG (1) | SG11202112888RA (enExample) |
| TW (1) | TWI757753B (enExample) |
| UY (1) | UY38717A (enExample) |
| WO (1) | WO2020240417A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114144169A (zh) | 2019-05-27 | 2022-03-04 | 托尔玛国际有限公司 | 醋酸亮丙瑞林组合物和使用其治疗乳腺癌的方法 |
| DK4135830T3 (da) | 2020-12-23 | 2024-10-28 | Tolmar International Ltd | Systemer og fremgangsmåder til blanding af sprøjteventilanordninger |
| CN115518144A (zh) * | 2021-06-26 | 2022-12-27 | 王婧宜 | 一种含有亮丙瑞林或其衍生物的口服药物组合物 |
| USD1029245S1 (en) | 2022-06-22 | 2024-05-28 | Tolmar International Limited | Syringe connector |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5702716A (en) | 1988-10-03 | 1997-12-30 | Atrix Laboratories, Inc. | Polymeric compositions useful as controlled release implants |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5324519A (en) | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
| JP4259610B2 (ja) | 1994-04-08 | 2009-04-30 | キューエルティー・ユーエスエイ・インコーポレーテッド | 液体デリバリー組成物 |
| US6565874B1 (en) | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
| US8470359B2 (en) | 2000-11-13 | 2013-06-25 | Qlt Usa, Inc. | Sustained release polymer |
| WO2007084460A2 (en) | 2006-01-18 | 2007-07-26 | Qps, Llc | Pharmaceutical compositions with enhanced stability |
| DK3660073T3 (da) * | 2007-02-15 | 2023-09-18 | Tolmar International Ltd | Poly(lactid-co-glycolid) med lav sprængning |
| DE202009010095U1 (de) | 2009-07-24 | 2009-10-22 | Chang, Ti-Li, Houli | Verbindungsvorrichtung für einen auswechselbaren, abgeschlossenen Sekret-Absaugkatheter |
| IL301603A (en) * | 2011-10-14 | 2023-05-01 | Genentech Inc | Pertuzumab, trastuzumab, docetaxel and carboplatin for use in the preoperative treatment of a patient |
| CN114144169A (zh) | 2019-05-27 | 2022-03-04 | 托尔玛国际有限公司 | 醋酸亮丙瑞林组合物和使用其治疗乳腺癌的方法 |
| KR102162217B1 (ko) | 2020-05-07 | 2020-10-06 | 주식회사 파인비엠 | 스태틱믹서를 갖는 연결장치를 구비한 시린지 결합 키트 |
| DK4135830T3 (da) | 2020-12-23 | 2024-10-28 | Tolmar International Ltd | Systemer og fremgangsmåder til blanding af sprøjteventilanordninger |
| AU2022331238A1 (en) | 2021-08-19 | 2024-02-01 | Carefusion 303, Inc. | Pivc-integrated hemolysis-reduction accessories with anti-spillage component for direct blood draw |
| FR3131618A1 (fr) | 2021-12-30 | 2023-07-07 | Parker Hannifin Emea Sarl | Dispositif de raccordement aseptique d’un tube |
-
2020
- 2020-05-26 CN CN202080052698.5A patent/CN114144169A/zh active Pending
- 2020-05-26 CA CA3141456A patent/CA3141456A1/en not_active Abandoned
- 2020-05-26 JP JP2021569057A patent/JP7664855B2/ja active Active
- 2020-05-26 BR BR112021023904A patent/BR112021023904A2/pt unknown
- 2020-05-26 EA EA202193257A patent/EA202193257A1/ru unknown
- 2020-05-26 PH PH1/2021/552976A patent/PH12021552976A1/en unknown
- 2020-05-26 AU AU2020284587A patent/AU2020284587B2/en active Active
- 2020-05-26 SG SG11202112888RA patent/SG11202112888RA/en unknown
- 2020-05-26 US US17/614,312 patent/US12453754B2/en active Active
- 2020-05-26 MX MX2021014540A patent/MX2021014540A/es unknown
- 2020-05-26 KR KR1020217042734A patent/KR20220041782A/ko active Pending
- 2020-05-26 EP EP20729830.8A patent/EP3975990A1/en active Pending
- 2020-05-26 WO PCT/IB2020/054984 patent/WO2020240417A1/en not_active Ceased
- 2020-05-27 TW TW109117742A patent/TWI757753B/zh active
- 2020-05-27 UY UY0001038717A patent/UY38717A/es not_active Application Discontinuation
- 2020-05-27 AR ARP200101496A patent/AR119021A1/es not_active Application Discontinuation
-
2021
- 2021-11-28 IL IL288503A patent/IL288503A/en unknown
-
2025
- 2025-09-30 US US19/345,133 patent/US20260027176A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022535694A5 (enExample) | ||
| US20220354956A1 (en) | Biodegradable drug delivery for hydrophobic compositions | |
| AU2005251462B2 (en) | Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons | |
| EP1250138B2 (en) | Fulvestrant formulation | |
| CN103491946B (zh) | 可生物降解的药物释放组合物 | |
| AU2004218893B2 (en) | Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels | |
| CN102933201B (zh) | 抗真菌药物组合物 | |
| US8877225B2 (en) | Controlled release copolymer formulation with improved release kinetics | |
| CN1178655C (zh) | 紫杉醇的与水混溶的药物组合物 | |
| CA2716576A1 (en) | Fulvestrant formulations | |
| KR102915096B1 (ko) | 연장 방출형 조성물을 이용한 중추성 성조숙증 어린이의 치료 방법 | |
| JP2022535694A (ja) | 乳がんを処置するためのリュープロリド酢酸塩組成物およびその使用方法 | |
| EP3821920A1 (en) | Combination for endoscopic surgery | |
| JP2024511353A5 (enExample) | ||
| JP2024501166A (ja) | フルベストラントの徐放性医薬組成物及びその製造方法 | |
| JP2023538265A (ja) | ホスホイノシチド３－キナーゼ阻害剤の製剤 | |
| CN101229150A (zh) | 含紫杉烷的温控缓释注射剂及其制备方法 | |
| KR20230094172A (ko) | 용해도가 개선된 풀베스트란트의 약학 조성물 및 그 제조 방법 | |
| JP2026500440A (ja) | 優れた薬物動態特性を有するフルベストラントの医薬組成物及びその製造方法 | |
| WO2024194781A1 (en) | Improved compositions | |
| KR20140147336A (ko) | 도세탁셀을 함유하는 액상 주사용 조성물 | |
| JP2023544311A (ja) | テストステロンの延長送達のための生分解性ポリマー送達システム | |
| HK1150021B (en) | Fulvestrant formulation |